Aurobindo Pharma Q3 FY19 net profit zooms 19.7% to Rs 712.2 crore, beats analysts#39; estimates

Aurobindo Pharma Q3 FY19 net profit zooms 19.7% to Rs 712.2 crore, beats analysts#39; estimates The rise net profit was aided by strong performance of US, Europe, emerging markets and active pharmaceutical ingredients business. Favorable foreign exchange too added to the profit.

No comments:

Post a Comment